JanOne Inc. (JAN)
2.23
0.09 (4.21%)
At close: Jul 12, 2024, 8:00 PM
4.21% (1D)
| Bid | n/a |
| Market Cap | 27.14M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.46M |
| EPS (ttm) | -4.4 |
| PE Ratio (ttm) | -0.5068181818181818 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 139,578 |
| Avg. Volume (20D) | 155,280 |
| Open | 2.14 |
| Previous Close | 2.14 |
| Day's Range | 2.14 - 2.37 |
| 52-Week Range | 0.22 - 5.26 |
| Beta | 2.16 |
About JAN
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical co...
Industry Waste Management
Sector Industrials
IPO Date Nov 7, 1991
Employees 5
Stock Exchange NASDAQ
Ticker Symbol JAN
Website https://www.janone.com
11 months ago
-3.14%
JanOne shares are trading higher after the company...
Unlock content with
Pro Subscription